BIFUNCTIONAL FUSION PROTEINS FOR UBIQUITIN-MEDIATED DEGRADATION

TARGETED DEGRADATION OF ALPHA-SYNUCLEIN

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE

GENE THERAPY FOR ANGELMAN SYNDROME

CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION

SECRETED UBE3A FOR TREATMENT OF NEUROLOGICAL DISORDERS

METHODS TO PREVENT TERATOGENICITY OF IMID LIKE MOLECULES AND IMID BASED DEGRADERS/PROTACS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS

MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME

METHODS OF MODULATING SEED AND ORGAN SIZE IN PLANTS

METHODS OF DETECTING UBE3A PROTEIN

Small Molecule Activators of Parkin Enzyme Function

CIRCULAR RNA MOLECULE AND USE THEREOF IN TARGETED DEGRADATION OF PROTEIN OF INTEREST

TARGETED PROTEIN SILENCING USING CHIMERAS BETWEEN ANTIBODIES AND UBIQUITINATION ENZYMES

BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF

RATIONAL THERAPEUTIC TARGETING OF ONCOGENIC IMMUNE SIGNALING STATES IN MYELOID MALIGNANCIES VIA THE UBIQUITIN CONJUGATING ENZYME UBE2N

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

METHODS FOR SCREENING UBIQUITIN LIGASE AGONISTS

LINEAR POLYFUNCTIONAL MULTIMER BIOMOLECULE COUPLED TO POLYUBIQUITIN LINKER AND USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

IN VIVO PRODUCTION OF PROTEINS

CRISPR/Cas system and method for genome editing and modulating transcription

UBIQUITIN VARIANT MODULATORS OF SCF E3 LIGASES AND THEIR USES

UBIQUITIN VARIANT MODULATORS OF HECT E3 LIGASES AND THEIR USES

PROTEIN EXPRESSION STRAINS

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

METHODS OF PREVENTING AND TREATING DISEASES CHARACTERIZED BY SYNAPTIC DYSFUNCTION AND NEURODEGENERATION INCLUDING ALZHEIMER'S DISEASE

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

In vivo production of proteins

Methods of modulating seed and organ size in plants

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes

Increasing ATOH1 life to drive sensorineural hair cell differentiation

Small molecule activators of Parkin enzyme function

BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN

Targeting WSB1 and pVHL to treat cancer

Universal N-glycan binding reagent

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

UBE2T peptides and vaccines containing the same

Modified Polynucleotides for the production of biologics and proteins associated with human disease

Probes and assays for measuring E3 ligase activity

Compositions and methods for modulating FMR1 expression

COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP

Cell-permeable (ICP) parkin recombinant protein and use thereof

Photocrosslinking reagents and methods of use thereof

Modified UBE3A gene for a gene therapy approach for angelman syndrome

BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF

ANTIBODIES AND METHODS FOR WNT PATHWAY-RELATED DISEASES

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modulation of UBE3A-ATS expression

In vivo production of proteins

Adenylation Enzyme Inhibitors

Ubiquitin variant modulators of SCF E3 ligases and their uses

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

Ubiquitin variant modulators of HECT E3 ligases and their uses

Universal N-glycan binding reagent

SUMOylation assay and related reagents

METHOD FOR PREDICTING RESPONSE TO THERAPY FOR CANCER

Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)

Targeting WSB1 and pVHL to treat cancer

RECURRENT TRANSFORMING UBR5-ZNF423 FUSION GENE IN EBV-ASSOCIATED NASOPHARYNGEAL CARCINOMA

MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

Methods of modulating ubiquitin ligase activity

Methods of modulating seed and organ size in plants

LAFORA'S DISEASE GENE

Parkin ligase activation methods and compositions

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modified polynucleotides for the production of proteins

PROTEIN INVOLVED IN DNA REPLICATION, AND MODULATION OF ITS ACTIVITY

ATSP1, AN E3 UBIQUITIN LIGASE, AND ITS USE

Modulators of itch ubiquitinase activity

Modified polynucleotides for the production of biologics and proteins associated with human disease

In vivo production of proteins

ADP-ribose detection reagents

ENGINEERED LOWER EUKARYOTIC HOST STRAINS DEFICIENT IN GRR1 ACTIVITY FOR RECOMBINANT PROTEIN

Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic Proteins

Recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma

Pharmaceutical composition containing core factor involved in proliferation and differentiation of central nervous cell

Methods of modulating ubiquitin ligase activity

Methods and Kits to Create Protein Substrate˜HECT-Ubiquitin Ligase Pairs

UBE2T peptides and vaccines containing the same

Modified polynucleotides for the production of cosmetic proteins and peptides

Mutations of the parkin gene, compositions, methods and uses

Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP

Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification

Transcriptional repression leading to parkinson's disease

Antibodies and methods for WNT pathway-related diseases

Method for therapeutic angiogenesis

Methods and compositions for inhibiting neddylation of proteins

High affinity SUMO traps

Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

Plants having stress related traits and methods for making the same

Engineered E2 for increasing the content of free LYS11-linked ubiquitin

GENES ENCODING PROTEINS ABLE TO ENHANCE HEAT RESISTANCE OF PLANTS AND MICROORGANISMS AND USES THEREOF

Bifunctional stapled polypeptides and uses thereof

Novel Ubiquitin-Isopeptide Probes

PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS

Transcriptional repression leading to Parkinson's disease

Treatment and prevention of pathological conditions using iduna related techniques and compositions

Method for therapeutic angiogenesis

Lafora's disease gene

Mutations of the parkin gene

E2EPF Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof

Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins

Method for increasing immunoreactivity

DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS

27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor

Modulators of Itch ubiquitinase activity

Compounds and methods for modulating activation of NF-κB

SiRNA silencing of genes expressed in cancer

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof

Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins

27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor

Posh nucleic acids, polypeptides and related methods

Antagonist of TEB4 and Methods of Use

Compounds and methods for modulating activation of NF-κB

Lafora's disease gene

Posh polypeptides, complexes and related methods

Mule: Mcl-1 ubiquitination ligase E3

Slim compositions and methods of use thereof

27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor

Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders

Diagnosis and treatment of fanconi's anemia

POSH nucleic acids, polypeptides and related methods

Posh nucleic acids, polypeptides and related methods

Compositions and methods for the modulation of viral maturation

Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders